Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Looks To Balance Device Sterilization With Environmental Concerns

Agency initiatives seek to advance ethylene oxide alternatives

Executive Summary

While half of all medical devices in the US are sterilized with ethylene oxide, emissions from the gas pose potential environmental hazards that are attracting federal action.

You may also be interested in...



AdvaMed Urges Biden Administration Not To Shut Down EtO Sterilization Facilities

The trade group says that the Biden Administration should consider the lack of alternatives to ethylene oxide sterilization when considering new regulations on EtO.

Sterigenics Wins Second Lawsuit In Ongoing Ethylene Oxide Court Battles

In the second trial over Sterigenics’ ethylene oxide plant emissions, the Cook County, IL jury found Stergiencs not liable for cancer in a woman who lived near the plant.

AdvaMed 2022: Phiex Technologies Takes Medtech Innovator Top Honors; A Look At All Finalists

Phiex Technologies Inc. won the audience vote for the grand prize of $350,000 and MedTech Innovator Award 2022 at the AdvaMed MedTech Conference in Boston, beating out finalists Moon Surgical, Limax Biosciences, LiveMetric and 52 North Health, which received $25,000 each.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel